The Chinese Journal Of Cancer is a research journal published by the BioMed Central Ltd. The P-ISSN of this journal is 1000467X.
Also, please check the following important details about chinese journal of cancer: Publisher, ISSN, Ranking, Indexing, Impact Factor (if applicable), Publication fee (APC), Review Time, and Acceptance Rate.
According to Clarivate's JCR, journals indexed in SCIE/SSCI have an impact factor.
| Journal Title: | Chinese Journal of Cancer |
| Publisher: | BioMed Central Ltd |
| P-ISSN: | 1000467X |
| Open Access: | Unpaywall Open Access |
| Status: | Inactive |
| Scopus Coverage: | 2002-2017 |
The chinese journal of cancer is indexed in:
An indexed journal means that the journal has gone through and passed a review process of certain requirements done by a journal indexer.
The Web of Science Core Collection includes the Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts & Humanities Citation Index (AHCI), and Emerging Sources Citation Index (ESCI).
According to journal website, the publication fee of chinese journal of cancer is around 1370 GBP.
The chinese journal of cancer has also Journal waiver policy (for developing countries, authors etc).
An article processing charge (APC), also known as a publication fee, is a fee which is sometimes charged to authors. Most commonly, it is involved in making a work available as open access (OA), in either a full OA journal or in a hybrid journal.
The Journal Publication Time means the average number of weeks between article submission and publication. According to the journal website, the chinese journal of cancer publishes research articles in 12 weeks on an average.
Visit to the official website of the journal/ conference to check the details about call for papers.
If your research is related to the scope of the journal, then visit the official website of chinese journal of cancer and send your manuscript.